Anaphylaxis vs Chronic Urticaria: Key Clinical Differences and Management
Anaphylaxis is a life-threatening systemic reaction requiring immediate intramuscular epinephrine, while chronic urticaria is a non-life-threatening condition lasting >6 weeks that responds to antihistamines and does not require epinephrine. 1
Critical Distinguishing Features
Anaphylaxis
Anaphylaxis involves multi-system involvement with acute onset (minutes to hours) and requires at least ONE of these criteria 1:
- Skin/mucosal symptoms PLUS respiratory compromise (wheeze, stridor, dyspnea, hypoxemia) OR hypotension/end-organ dysfunction
- Two or more organ systems involved after allergen exposure: skin, respiratory, cardiovascular, or gastrointestinal symptoms
- Isolated hypotension after known allergen exposure (systolic BP <90 mmHg in adults or >30% drop from baseline)
Key point: Anaphylaxis can occur WITHOUT skin manifestations—isolated hypotension after insect sting or isolated respiratory symptoms can be anaphylaxis 1
Chronic Urticaria
Chronic urticaria presents with recurrent wheals and/or angioedema lasting >6 weeks WITHOUT multi-system involvement 2:
- Isolated skin symptoms: pruritic wheals that resolve within 24 hours
- No respiratory compromise, hypotension, or gastrointestinal symptoms
- Chronic time course (>6 weeks) vs acute onset of anaphylaxis
- No identifiable trigger in chronic spontaneous urticaria (most common subtype, >75% of cases) 3
Critical caveat: Isolated allergen-associated urticaria must be distinguished from anaphylaxis—if only skin symptoms are present without respiratory or cardiovascular involvement, this is NOT anaphylaxis 1
Management Algorithms
Anaphylaxis Management
First-line treatment is ALWAYS intramuscular epinephrine—never delay for antihistamines or corticosteroids 1:
- Immediate IM epinephrine (anterolateral thigh)
- Adjunctive therapies AFTER epinephrine:
Important: Antihistamines lack vasoconstrictive, bronchodilatory, and mast cell stabilization properties of epinephrine and take 60-120 minutes to reach peak plasma levels—far too slow for life-threatening reactions 1
Chronic Urticaria Management
Step-wise approach prioritizing antihistamines 2:
- First-line: Standard-dose second-generation H1-antihistamines
- After 2-4 weeks if inadequate control: Up-dose antihistamines up to 4-fold
- If still uncontrolled: Add omalizumab 300mg every 4 weeks (achieves control in ~70% of antihistamine-refractory cases) 2, 4
- Third-line: Cyclosporine (up to 5mg/kg body weight) for severe refractory cases 2
Step-down protocol: Once complete control achieved for ≥3 consecutive months, reduce antihistamine dose by no more than 1 tablet per month 2
Common Pitfalls to Avoid
In Anaphylaxis
- Never give antihistamines or corticosteroids BEFORE epinephrine—mortality from anaphylaxis is <0.5% per episode, but delay in epinephrine is associated with death 1
- Don't wait for all diagnostic criteria to be met—clinical judgment supersedes criteria. A patient with generalized urticaria immediately after immunotherapy injection may warrant epinephrine for impending anaphylaxis 1
- Don't assume skin involvement is required—anaphylaxis can present without cutaneous manifestations 1
In Chronic Urticaria
- Don't use epinephrine—isolated urticaria without systemic symptoms responds to antihistamines 1
- Don't perform extensive laboratory testing—diagnosis is clinical; labs should be guided by history, not routine 3
- Don't confuse with anaphylaxis—some chronic urticaria patients may experience systemic flares fulfilling anaphylaxis criteria, but these are distinct episodes requiring separate evaluation 5
Overlapping Presentations
A subset of chronic urticaria patients can experience systemic flares that meet anaphylaxis criteria 5. These patients paradoxically have:
- Well-controlled urticaria with antihistamines alone
- Lower need for omalizumab escalation
- Higher peripheral lymphocyte counts
- Gastrointestinal involvement predicts recurrent systemic flares (OR 8.24) 5
When this occurs: Treat the acute systemic flare as anaphylaxis with epinephrine, but continue managing the underlying chronic urticaria with antihistamines 5